Physician profile
Nancy Prantl
NPI 1205203098
$343.90
in general payments reported to CMS, 2019-2025
10 companies · $58.60 in 2025
The $58.60 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $11.77 · 2023: $153 · 2024: $121 · 2025: $58.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $332.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $332.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $96.28 | 2024-2025 | Freestyle Libre 3 |
| Takeda Pharmaceuticals U.S.A., INC. | $40.38 | 2023 | Trintellix |
| Corium, LLC | $39.87 | 2023 | Azstarys |
| Otsuka America Pharmaceutical, INC. | $36.30 | 2023 | Nuedexta |
| Abbvie INC. | $33.24 | 2021-2023 | |
| Shield Therapeutics INC | $25.28 | 2025 | |
| Hologic Sales and Service, LLC | $21.40 | 2024 | Thinprep 2000 Processor, Aptima |
| Indivior INC. | $21.05 | 2024 | Sublocade |
| Ani Pharmaceuticals, INC. | $15.14 | 2025 | Purified Cortrophin Gel |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $14.96 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Prantl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.